Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and Reviews, 2019 - Taylor & Francis
Background There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

[HTML][HTML] Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and Reviews, 2019 - dovepress.com
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic …, 2019 - portal.findresearcher.sdu.dk
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

[HTML][HTML] Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and Reviews, 2019 - ncbi.nlm.nih.gov
Background There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

[PDF][PDF] Platelet-rich plasma (PRP) treatment of noninsertional achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - 2019 - researchgate.net
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and Reviews, 2019 - europepmc.org
Background There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

[PDF][PDF] Platelet-rich plasma (PRP) treatment of noninsertional achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - 2019 - pdfs.semanticscholar.org
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic research and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and …, 2019 - search.proquest.com
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …

Platelet-rich plasma (PRP) treatment of noninsertional Achilles tendinopathy in a two case series: no significant difference in effect between leukocyte-rich and …

K Hanisch, N Wedderkopp - Orthopedic Research and Reviews, 2020 - go.gale.com
Background: There is a theoretical basis for the treatment of chronic tendinopathies by
platelet-rich plasma (PRP), and it can, therefore, be considered a possible treatment of …